Maximum Strength Antacid Cherry

Description

This product is identified by the code 51945-4 and is associated with the root ID 7d780ac6-54d1-cc27-e053-2991aa0a155e. The effective date of the labeling is October 2, 2014. The package label includes a visual representation, which is available in JPEG format, referenced as "CVS ANT MAX CHRY.jpg." The label is designed for professional use and adheres to the standards set forth in the relevant code system (2.16.840.1.113883.6.1).

Uses and Indications

This drug is indicated for the relief of heartburn, sour stomach, acid indigestion, and symptoms associated with gas.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The medication should be shaken well before use to ensure proper mixing of the formulation.

For adults and children aged 12 years and older, the recommended dosage is 2 to 4 teaspoonfuls taken between meals, at bedtime, or as directed by a healthcare professional. It is important not to exceed 8 teaspoonfuls within a 24-hour period, and the maximum dosage should not be used for more than 2 weeks.

For children under 12 years of age, it is advised to consult a healthcare professional for appropriate dosing recommendations.

Contraindications

Use is contraindicated in individuals who are unable to keep the product out of reach of children. This precaution is necessary to prevent accidental ingestion or misuse by pediatric patients. No other contraindications have been identified.

Warnings and Precautions

Patients should consult a healthcare professional prior to use if they have a history of kidney disease or are on a magnesium-restricted diet, as these conditions may influence the safety and efficacy of the treatment. Additionally, it is imperative to seek advice from a doctor or pharmacist if the patient is currently taking any prescription medications, as antacids may interact with certain drugs, potentially leading to adverse effects.

In the event that symptoms persist for more than two weeks, it is crucial to discontinue use and consult a healthcare provider for further evaluation. For individuals who are pregnant or breastfeeding, it is recommended to seek guidance from a health professional before initiating use to ensure safety for both the mother and child.

To ensure safety, this product should be kept out of reach of children to prevent accidental ingestion or misuse.

Side Effects

Patients should be aware of certain warnings associated with the use of this medication. It is advised to consult a doctor before use if there is a history of kidney disease or if the patient is on a magnesium-restricted diet. Additionally, patients should seek advice from a doctor or pharmacist if they are currently taking any prescription medications, as antacids may interact with specific drugs.

In the event that symptoms persist for more than two weeks, patients are instructed to discontinue use and consult a doctor. Furthermore, pregnant or breastfeeding individuals should consult a health professional prior to using this medication to ensure safety for both the mother and child.

Drug Interactions

Antacids may interact with various prescription medications, potentially affecting their absorption and efficacy. It is advisable to monitor the timing of antacid administration in relation to other medications to minimize these interactions. Specifically, antacids should be taken at least 2 hours apart from other drugs to ensure optimal therapeutic effects and to avoid diminished efficacy of the prescribed treatments.

Packaging & NDC

Below are the non-prescription pack sizes of Maximum Strength Antacid Cherry (aluminum hydroxide, magnesium hydroxide, simethicone). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a healthcare professional before use. For adolescents and children aged 12 years and older, the recommended dosage is 2 to 4 teaspoonfuls taken between meals, at bedtime, or as directed by a healthcare provider. It is important to note that the maximum dosage should not exceed 8 teaspoonfuls within a 24-hour period, and this maximum dosage should not be used for more than 2 weeks.

Geriatric Use

Elderly patients should consult a healthcare provider prior to using this medication, particularly if they have a history of kidney disease. It is also advisable for geriatric patients to seek guidance from a doctor or pharmacist if they are currently taking any prescription medications, as antacids may interact with certain drugs.

For adults and children aged 12 years and older, the recommended dosage is 2 to 4 teaspoonfuls taken between meals, at bedtime, or as directed by a healthcare professional. It is crucial for elderly patients to adhere to the maximum dosage limit of 8 teaspoonfuls within a 24-hour period and to avoid using the maximum dosage for more than 2 weeks. For children under 12 years of age, consultation with a doctor is recommended before use.

Close monitoring of elderly patients is advised to ensure safety and efficacy, particularly in the context of potential drug interactions and the management of underlying health conditions.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully considered in these populations to ensure the safety of both the mother and the fetus or infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment should consult a healthcare professional prior to use, particularly if they have a history of kidney disease. It is essential to assess renal function and consider potential dosing adjustments or monitoring requirements based on the degree of impairment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise, as the clinical presentation can vary depending on the substance involved and the individual patient's response. Common symptoms of overdose may include, but are not limited to, altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, providing supplemental oxygen, and ensuring adequate circulation. The use of activated charcoal may be considered if the patient presents within a suitable timeframe and is deemed appropriate based on clinical judgment.

Additionally, it is crucial to consult local poison control centers or toxicology experts for guidance on specific management strategies tailored to the substance involved in the overdose. Continuous monitoring and supportive care remain the cornerstones of effective management in such scenarios.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion or misuse. It is important to emphasize the necessity of proper storage to ensure the safety of young individuals.

Storage and Handling

The product is supplied in a configuration that ensures optimal handling and storage. It should be stored at room temperature, away from extreme temperatures. It is essential to protect the product from freezing to maintain its integrity. Additionally, the container must be kept tightly closed to prevent contamination and preserve the quality of the product.

Additional Clinical Information

The medication is administered orally, with the recommended dosage for adults and children aged 12 years and older being 2 to 4 teaspoonfuls between meals or at bedtime, as directed by a physician. Patients should not exceed 8 teaspoonfuls within a 24-hour period or use the maximum dosage for more than 2 weeks. For children under 12 years of age, consultation with a doctor is advised prior to use.

Clinicians should counsel patients to seek medical advice before use if they have kidney disease or are on a magnesium-restricted diet. Additionally, patients taking prescription medications should consult a doctor or pharmacist before use. If symptoms persist beyond 2 weeks, patients are advised to discontinue use and consult a physician. Pregnant or breastfeeding individuals should also seek professional guidance before using the medication. It is important to keep the product out of reach of children.

Drug Information (PDF)

This file contains official product information for Maximum Strength Antacid Cherry, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)